CorneaGen
PrivateLast Round
Series B
Oct 7, 2019
Total Funding Raised
$47M
Company Overview
CorneaGen is a medical device and biotechnology company that provides corneal transplant tissue, surgical instruments, and innovative therapeutic solutions to improve outcomes for patients with ocular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CorneaGen Comparables
Compare CorneaGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brightstar Therapeutics | 80% | |
| Eversight | 76% | |
| KeraNatural | 76% | |
CorneaGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 7, 2019 | ||||
| Series A | Oct 18, 2016 |
Key People
Founding team and executive leadership
CorneaGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Petrichor Healthcare Capital Management | Series B |
| Flying L Partners | Series A, Series B |
| Falcon Vision | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2019
$37M round led by Petrichor Healthcare Capital Management and Flying L Partners.
- Oct 18, 2016
$10M round led by Flying L Partners
CorneaGen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CorneaGen's valuation, stock price, and market status.